Potassium Bromate Enhances N-Ethyl-N-Hydroxyethylnitrosamine–Induced Kidney Carcinogenesis Only at High Doses in Wistar Rats: Indication of the Existence of an Enhancement Threshold

As susceptibility to carcinogens varies considerably among different strains of experimental animals, evaluation of dose-response relationships for genotoxic carcinogen in different strains is indispensable for risk assessment. Potassium bromate (KBrO3) is a genotoxic carcinogen inducing kidney cancers at high doses in male F344 rats, but little is known about its carcinogenic effects in other strains of rats. The purpose of the present study was to determine dose-response relationships for carcinogenic effects of KBrO3 on N-ethyl-N-hydroxyethylnitrosamine (EHEN)–induced kidney carcinogenesis in male Wistar rats. We found that KBrO3 showed significant enhancement effects on EHEN-induced kidney carcinogenesis at above 250 ppm but not at doses of 125 ppm and below when evaluated in terms of induction of either preneoplastic lesions or tumors in male Wistar rats. Furthermore, KBrO3 significantly increased the formation of oxidative DNA damage at doses of 125 and above but not at doses of 30 ppm and below in kidneys. These results demonstrated that low doses of KBrO3 exert no effects on development of EHEN-initiated kidney lesions and induction of oxidative DNA damage. Taking account of previous similar findings in male F344 rats, it is strongly suggested that a threshold dose exists for enhancement effects of KBrO3 on kidney carcinogenesis in rats.

[1]  S. Fukushima,et al.  Lack of mutagenic and toxic effects of low dose potassium bromate on kidneys in the Big Blue rat. , 2008, Mutation research.

[2]  A. Deangelo,et al.  Kidney Toxicogenomics of Chronic Potassium Bromate Exposure in F344 Male Rats , 2006, Translational oncogenomics.

[3]  K. Kanki,et al.  In vivo mutagenicity and initiation following oxidative DNA lesion in the kidneys of rats given potassium bromate , 2006, Cancer science.

[4]  S. Fukushima,et al.  Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide‐induced liver damage in rats , 2006, Cancer science.

[5]  T. Umemura,et al.  Etiology of bromate-induced cancer and possible modes of action-studies in Japan. , 2006, Toxicology.

[6]  Tao Chen,et al.  Mutagenicity of bromate: implications for cancer risk assessment. , 2006, Toxicology.

[7]  Tanya Moore,et al.  Molecular biomarkers of oxidative stress associated with bromate carcinogenicity. , 2006, Toxicology.

[8]  S. Fukushima,et al.  Existence of No Hepatocarcinogenic Effect Levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without Coadministration with Ethanol , 2006, Toxicologic pathology.

[9]  S. Fukushima,et al.  Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats. , 2006, Cancer letters.

[10]  S. Fukushima,et al.  Dose‐dependence of promotion of 2‐amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline‐induced rat hepatocarcinogenesis by ethanol: Evidence for a threshold , 2005, Cancer science.

[11]  S. Fukushima,et al.  Lack of large intestinal carcinogenicity of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine at low doses in rats initiated with azoxymethane , 2005, International journal of cancer.

[12]  T. Ushijima,et al.  No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  T. Tsukamoto,et al.  Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b]pyridine. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  K. Kanki,et al.  Dose‐related changes of oxidative stress and cell proliferation in kidneys of male and female F344 rats exposed to potassium bromate , 2004, Cancer science.

[15]  Micheline Kirsch-Volders,et al.  Indirect mechanisms of genotoxicity. , 2003, Toxicology letters.

[16]  T. Tsukamoto,et al.  Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. , 2003, Cancer letters.

[17]  T. Tsukamoto,et al.  Lack of a Dose‐response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2‐Amino‐3,8‐dimethylimidazo[4,5‐f]quinoxaline or N‐Nitrosodiethylamine , 2002, Japanese journal of cancer research : Gann.

[18]  S. Fukushima,et al.  Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. , 2002, Carcinogenesis.

[19]  T. Hirano,et al.  Changes in DNA 8-hydroxyguanine levels, 8-hydroxyguanine repair activity, and hOGG1 and hMTH1 mRNA expression in human lung alveolar epithelial cells induced by crocidolite asbestos. , 2001, Carcinogenesis.

[20]  M. Yamada,et al.  Semi-quantitative evaluation of genotoxic activity of chemical substances and evidence for a biological threshold of genotoxic activity. , 2000, Mutation research.

[21]  A Kopp-Schneider,et al.  Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  K M Walsh,et al.  Spontaneous neoplasms in control Wistar rats: a comparison of reviews. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  N. Konishi,et al.  Rodent species and strain difference in kidney and lung pathology induced by N-ethyl-N-hydroxyethylnitrosamine. , 1994 .

[24]  S. Richardson,et al.  Ozonation Byproducts: Identification of Bromohydrins from the Ozonation of Natural Waters with Enhanced Bromide Levels , 1992 .

[25]  M. Takahashi,et al.  Toxicity and carcinogenicity of potassium bromate--a new renal carcinogen. , 1990, Environmental health perspectives.

[26]  T Sofuni,et al.  Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicals. , 1988, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  T. Imazawa,et al.  Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration. , 1986, Journal of the National Cancer Institute.

[28]  T. Imazawa,et al.  Dose-related enhancing effect of potassium bromate on renal tumorigenesis in rats initiated with N-ethyl-N-hydroxyethyl-nitrosamine. , 1985, Japanese journal of cancer research : Gann.

[29]  T Sofuni,et al.  Primary mutagenicity screening of food additives currently used in Japan. , 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  S. Flora.  Detoxification of Genotoxic Compounds as a Threshold Mechanism Limiting Their Carcinogenicity , 1984 .

[31]  M. Ishidate,et al.  Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation--a comparative study on mutagens and carcinogens. , 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.